United States · FDA National Drug Code directory

NARCAN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
69547-627_5943126a-0a41-d369-e063-6294a90ac238
Product NDC
69547-627
Form
SPRAY
Composition / generic term
naloxone hydrochloride nasal
Labeler
Emergent Devices Inc.
Marketing category
NDA
Marketing start / end (source format)
20230828
Source listing expiry
20271231

Source-listed ingredients

  • NALOXONE HYDROCHLORIDE — 4 mg/.1mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-02) / .1 mL in 1 VIAL, SINGLE-DOSE · 69547-627-02
  • 1 CASE in 1 CARTON (69547-627-05) / 2 VIAL, SINGLE-DOSE in 1 CASE / .1 mL in 1 VIAL, SINGLE-DOSE · 69547-627-05
  • 6 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-06) / .1 mL in 1 VIAL, SINGLE-DOSE · 69547-627-06
  • 24 VIAL, SINGLE-DOSE in 1 CARTON (69547-627-24) / .1 mL in 1 VIAL, SINGLE-DOSE · 69547-627-24

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
NARCAN — United States | Molindra Medicines